Literature DB >> 21182575

Endogenous GDNF in ventral tegmental area and nucleus accumbens does not play a role in the incubation of heroin craving.

Mikko Airavaara1, Charles L Pickens, Anna L Stern, Kristina A Wihbey, Brandon K Harvey, Jennifer M Bossert, Qing-Rong Liu, Barry J Hoffer, Yavin Shaham.   

Abstract

Glial cell line-derived neurotrophic factor (GDNF) activity in ventral tegmental area (VTA) mediates the time-dependent increases in cue-induced cocaine-seeking after withdrawal (incubation of cocaine craving). Here, we studied the generality of these findings to incubation of heroin craving. Rats were trained to self-administer heroin for 10 days (6 hours/day; 0.075 mg/kg/infusion; infusions were paired with a tone-light cue) and tested for cue-induced heroin-seeking in extinction tests after 1, 11 or 30 withdrawal days. Cue-induced heroin seeking was higher after 11 or 30 days than after 1 day (incubation of heroin craving), and the time-dependent increases in extinction responding were associated with time-dependent changes in GDNF mRNA expression in VTA and nucleus accumbens. Additionally, acute accumbens (but not VTA) GDNF injections (12.5 µg/side) administered 1-3 hours after the last heroin self-administration training session enhanced the time-dependent increases in extinction responding after withdrawal. However, the time-dependent increases in extinction responding after withdrawal were not associated with changes in GDNF protein expression in VTA and accumbens. Additionally, interfering with endogenous GDNF function by chronic delivery of anti-GDNF monoclonal neutralizing antibodies (600 ng/side/day) into VTA or accumbens had no effect on the time-dependent increases in extinction responding. In summary, heroin self-administration and withdrawal regulate VTA and accumbens GDNF mRNA expression in a time-dependent manner, and exogenous GDNF administration into accumbens but not VTA potentiates cue-induced heroin seeking. However, based on the GDNF protein expression and the anti-GDNF monoclonal neutralizing antibodies manipulation data, we conclude that neither accumbens nor VTA endogenous GDNF mediates the incubation of heroin craving.
© 2010 Society for the Study of Addiction. No claim to original US government works.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21182575      PMCID: PMC3059093          DOI: 10.1111/j.1369-1600.2010.00281.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  64 in total

1.  Role for GDNF in biochemical and behavioral adaptations to drugs of abuse.

Authors:  C J Messer; A J Eisch; W A Carlezon; K Whisler; L Shen; D H Wolf; H Westphal; F Collins; D S Russell; E J Nestler
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

2.  Neuroadaptation. Incubation of cocaine craving after withdrawal.

Authors:  J W Grimm; B T Hope; R A Wise; Y Shaham
Journal:  Nature       Date:  2001-07-12       Impact factor: 49.962

Review 3.  Neurobiology of relapse to heroin and cocaine seeking: a review.

Authors:  Uri Shalev; Jeffrey W Grimm; Yavin Shaham
Journal:  Pharmacol Rev       Date:  2002-03       Impact factor: 25.468

4.  Differential patterns of nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 mRNA and protein levels in developing regions of rat brain.

Authors:  K P Das; S L Chao; L D White; W T Haines; G J Harry; H A Tilson; S Barone
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

Review 5.  Effects of psychomotor stimulants on glutamate receptor expression.

Authors:  Marina E Wolf
Journal:  Methods Mol Med       Date:  2003

6.  Nucleus accumbens-derived glial cell line-derived neurotrophic factor is a retrograde enhancer of dopaminergic tone in the mesocorticolimbic system.

Authors:  Jun Wang; Sebastien Carnicella; Somayeh Ahmadiantehrani; Dao-Yao He; Segev Barak; Viktor Kharazia; Sami Ben Hamida; Agustin Zapata; Toni S Shippenberg; Dorit Ron
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

7.  The neural circuitry underlying reinstatement of heroin-seeking behavior in an animal model of relapse.

Authors:  J L Rogers; S Ghee; R E See
Journal:  Neuroscience       Date:  2007-10-22       Impact factor: 3.590

8.  Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats.

Authors:  U Shalev; M Morales; B Hope; J Yap; Y Shaham
Journal:  Psychopharmacology (Berl)       Date:  2001-06       Impact factor: 4.530

9.  Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving.

Authors:  Jeffrey W Grimm; Lin Lu; Teruo Hayashi; Bruce T Hope; Tsung-Ping Su; Yavin Shaham
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

10.  MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons.

Authors:  Penka Petrova; Andrei Raibekas; Jonathan Pevsner; Noel Vigo; Mordechai Anafi; Mary K Moore; Amy E Peaire; Viji Shridhar; David I Smith; John Kelly; Yves Durocher; John W Commissiong
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

View more
  33 in total

1.  Role of nucleus accumbens microRNA-181a and MeCP2 in incubation of heroin craving in male rats.

Authors:  Wenjin Xu; Qingxiao Hong; Zi Lin; Hong Ma; Weisheng Chen; Dingding Zhuang; Huaqiang Zhu; Miaojun Lai; Dan Fu; Wenhua Zhou; Huifen Liu
Journal:  Psychopharmacology (Berl)       Date:  2021-05-01       Impact factor: 4.530

2.  An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).

Authors:  Russell W Brown; Seth L Kirby; Adam R Denton; John M Dose; Elizabeth D Cummins; Wesley Drew Gill; Katherine C Burgess
Journal:  Schizophr Res       Date:  2017-03-14       Impact factor: 4.939

3.  Cue-induced nicotine-seeking behavior after withdrawal with or without extinction in rats.

Authors:  Athina Markou; Jie Li; Kearny Tse; Xia Li
Journal:  Addict Biol       Date:  2016-11-28       Impact factor: 4.280

4.  Effect of chronic delivery of the Toll-like receptor 4 antagonist (+)-naltrexone on incubation of heroin craving.

Authors:  Florence R Theberge; Xuan Li; Sarita Kambhampati; Charles L Pickens; Robyn St Laurent; Jennifer M Bossert; Michael H Baumann; Mark R Hutchinson; Kenner C Rice; Linda R Watkins; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

5.  Incubation of methamphetamine and palatable food craving after punishment-induced abstinence.

Authors:  Irina N Krasnova; Nathan J Marchant; Bruce Ladenheim; Michael T McCoy; Leigh V Panlilio; Jennifer M Bossert; Yavin Shaham; Jean L Cadet
Journal:  Neuropsychopharmacology       Date:  2014-03-03       Impact factor: 7.853

6.  Dopamine D1 Receptor Within Basolateral Amygdala Is Involved in Propofol Relapse Behavior Induced by Cues.

Authors:  Sicong Wang; Xin Wang; Wenxuan Lin; Suhao Bao; Benfu Wang; Binbin Wu; Ying Su; Qingquan Lian
Journal:  Neurochem Res       Date:  2018-10-24       Impact factor: 3.996

7.  Dopamine D2 receptor activation leads to an up-regulation of glial cell line-derived neurotrophic factor via Gβγ-Erk1/2-dependent induction of Zif268.

Authors:  Somayeh Ahmadiantehrani; Dorit Ron
Journal:  J Neurochem       Date:  2013-02-27       Impact factor: 5.372

8.  Recent developments in animal models of drug relapse.

Authors:  Nathan J Marchant; Xuan Li; Yavin Shaham
Journal:  Curr Opin Neurobiol       Date:  2013-01-29       Impact factor: 6.627

Review 9.  The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research.

Authors:  Jennifer M Bossert; Nathan J Marchant; Donna J Calu; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2013-05-18       Impact factor: 4.530

10.  Role of orbitofrontal cortex neuronal ensembles in the expression of incubation of heroin craving.

Authors:  Sanya Fanous; Evan M Goldart; Florence R M Theberge; Jennifer M Bossert; Yavin Shaham; Bruce T Hope
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.